Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.

Marshall R. Posner, J. Belliveau, Alan B. Weitberg, Kert D. Sabbath, Michael C. Wiemann, F J Cummings, Peter A. CalabresiPubMed 1987

Abstract

Twenty-one evaluable patients with metastatic colorectal carcinoma were treated with a combination of continuous-infusion cisplatin (25 mg/m2/day X 3 days) and bolus 5-fluorouracil (400 mg/m2/day X 3 days). Toxicity was minimal. Seven patients (33%) responded. All responses were observed among the 16 previously untreated patients (44%) and lasted a median of 30 weeks. The results indicate the need for phase III trials of this treatment.
BibTeX
@inproceedings{posner1987continuous,
  author = {Marshall R. Posner and J. Belliveau and Alan B. Weitberg and Kert D. Sabbath and Michael C. Wiemann and F J Cummings and Peter A. Calabresi},
  title = {{Continuous-infusion cisplatin and bolus 5-fluorouracil in colorectal carcinoma.}},
  booktitle = {PubMed},
  year = {1987},
}

Loading related content...

Figure